Cargando…
Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma
As a major contributor of chemotherapy resistance and malignant recurrence, glioma stem cells (GSCs) have been proposed as a target for the treatment of gliomas. To evaluate the therapeutic potential of quetiapine (QUE), an atypical antipsychotic, for the treatment of malignant glioma, we establishe...
Autores principales: | Wang, Yun, Huang, Nanxin, Li, Hongli, Liu, Shubao, Chen, Xianjun, Yu, Shichang, Wu, Nan, Bian, Xiu-Wu, Shen, Hai-Ying, Li, Chengren, Xiao, Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514926/ https://www.ncbi.nlm.nih.gov/pubmed/28415586 http://dx.doi.org/10.18632/oncotarget.16400 |
Ejemplares similares
-
Quetiapine Inhibits Microglial Activation by Neutralizing Abnormal STIM1-Mediated Intercellular Calcium Homeostasis and Promotes Myelin Repair in a Cuprizone-Induced Mouse Model of Demyelination
por: Wang, Hanzhi, et al.
Publicado: (2015) -
Drug Repurposing of Metabolic Agents in Malignant Glioma
por: Seliger, Corinna, et al.
Publicado: (2018) -
Prognostic Implication of Histological Oligodendroglial Tumor Component: Clinicopathological Analysis of 111 Cases of Malignant Gliomas
por: Kanno, Hiromi, et al.
Publicado: (2012) -
Genes of the Ubiquitin Proteasome System Qualify as Differential Markers in Malignant Glioma of Astrocytic and Oligodendroglial Origin
por: Vriend, Jerry, et al.
Publicado: (2022) -
Disulfiram in glioma: Literature review of drug repurposing
por: Zhong, Shiyu, et al.
Publicado: (2022)